Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
MA 05 - Immuno-Oncology: Novel Biomarker Candidates
- 15:45 - 17:30
- 10/16/2017
- Location: Room 303 + 304
- Type: Mini Oral
- Track: Immunology and Immunotherapy
- Moderators:Yoichi Nakanishi, P. Mitchell
-
+
MA 05.02 - STK11/LKB1 Loss of Function Genomic Alterations Predict Primary Resistance to PD-1/PD-L1 Axis Blockade in KRAS-Mutant NSCLC
15:50 - 15:55 | Presenter: Ferdinandos Skoulidis | Author(s): L.A. Albacker, M.D. Hellmann, M.M. Awad, Justin F Gainor, M.E. Goldberg, A.B. Schrock, L. Gay, J. Elvin, Jeffrey S. Ross, H. Rizvi, B. Carter, J. Erasmus, D.F. Halpenny, A. Plodkowski, N. Long, M. Nishino-Habatu, W.L. Denning, J. Rodriguez-Canales, P. Villalobos, E.R. Parra Cuentas, L.M. Sholl, J.L. Sauter, Y.Y. Elamin, Jianjun Zhang, G.C. Leonardi, Kwok-Kin Wong, P.J. Stephens, Vassiliki A Papadimitrakopoulou, Ignacio I. Wistuba, J.D. Wolchok, Alice Shaw, Pasi A Jänne, Charles M Rudin, V.A. Miller, John V Heymach
- Abstract
Loading...
-
+
OA 09 - EGFR TKI Resistance
- 11:00 - 12:30
- 10/17/2017
- Location: Room 301 + 302
- Type: Oral
- Track: Advanced NSCLC
- Moderators:Thanyanan Reungwetwattana, Lecia V Sequist
-
+
OA 09.05 - Identification of Novel Potentially Targetable Genomic Alterations in Paired Tumors with Acquired EGFR TKI Resistance by NGS
11:45 - 11:55 | Presenter: Jacqulyne Ponville Robichaux | Author(s): Y.Y. Elamin, Jianjun Zhang, A. Futreal, E. Roarty, W. Rinsurongkawong, J. Lewis, H.T. Tran, Stephen Swisher, John V Heymach
- Abstract
Loading...
-
+
OA 12 - Emerging Genomic Targets
- 11:00 - 12:30
- 10/18/2017
- Location: F203 + F204 (Annex Hall)
- Type: Oral
- Track: Advanced NSCLC
- Moderators:H. Akita, Maurice Pérol
-
+
OA 12.01 - The Preclinical and Clinical Activity of Poziotinib, a Potent, Selective Inhibitor of EGFR Exon 20 Mutant NSCLC
11:00 - 11:10 | Presenter: Y.Y. Elamin | Author(s): Jacqulyne Ponville Robichaux, Vincent K Lam, Anne Tsao, C. Lu, G. Blumenschein, J. Kurie, Julie R Brahmer, S. Li, T. Chen, A. Estrada-Bernal, A. Truini, M. Nilsson, A.T. Le, Z. Tan, S. Zhang, Robert C. Doebele, K. Politi, Z. Yang, S. Liu, Kwok-Kin Wong, John V Heymach
- Abstract
Loading...